Guardant Health Grant Program Links Shield Test Access To Growth Story

Simply Wall St.02-14

Guardant Health has launched a Community Colorectal Cancer Screening Grant Program ahead of Colorectal Cancer Awareness Month. The program offers free access to its FDA approved Shield blood test for ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2611648681?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","is_english":true,"pubTime":"2026-02-14 00:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611648681","market":"nz","top_or_hot":-1,"title":"Guardant Health Grant Program Links Shield Test Access To Growth Story","media":"Simply Wall St.","content":"<div>\n<p>Guardant Health has launched a Community Colorectal Cancer Screening Grant Program ahead of Colorectal Cancer Awareness Month. The program offers free access to its FDA approved Shield blood test for ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-grant-program-links-shield-test-access-to-gr\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guardant Health Grant Program Links Shield Test Access To Growth Story</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuardant Health Grant Program Links Shield Test Access To Growth Story\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-14 00:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-grant-program-links-shield-test-access-to-gr><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Guardant Health has launched a Community Colorectal Cancer Screening Grant Program ahead of Colorectal Cancer Awareness Month. The program offers free access to its FDA approved Shield blood test for ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-grant-program-links-shield-test-access-to-gr\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-grant-program-links-shield-test-access-to-gr","article_id":"2611648681","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-grant-program-links-shield-test-access-to-gr","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2611648681","pubTimestamp":1771000194,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Guardant Health has launched a Community Colorectal Cancer Screening Grant Program ahead of Colorectal Cancer Awareness Month.\nThe program offers free access to its FDA approved Shield blood test for primary colorectal cancer screening in adults 45 and older.\nThe initiative targets underserved communities by pairing no cost tests with education and outreach on early cancer detection.\n\nFor investors tracking Guardant Health, NasdaqGS:GH, the grant program adds a fresh public health angle to a...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4196":"保健护理服务","BK4585":"ETF&股票定投概念","BK4535":"淡马锡持仓","GH":"Guardant Health Inc.","BK4551":"寇图资本持仓"},"translate_title":"Guardant Health Grant计划将Shield Test Access与成长故事联系起来","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GH":0.9},"content_text":"Guardant Health has launched a Community Colorectal Cancer Screening Grant Program ahead of Colorectal Cancer Awareness Month. The program offers free access to its FDA approved Shield blood test for primary colorectal cancer screening in adults 45 and older. The initiative targets underserved communities by pairing no cost tests with education and outreach on early cancer detection.  For investors tracking Guardant Health, NasdaqGS:GH, the grant program adds a fresh public health angle to a stock that has seen a very large 3 year return of about 258.2% and a 1 year return of 118.7%. Shares most recently closed at $102.76, with shorter term moves including a 4.5% gain over the past week and a 3.9% decline over the past 30 days. This new program may be worth watching if you care about how Guardant Health’s FDA approved Shield blood test is used in real world screening programs. Expanded access in underserved communities could provide more data on test adoption and patient reach, which some investors use to gauge how a product is being incorporated into everyday care. Stay updated on the most important news stories for Guardant Health by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Guardant Health. NasdaqGS:GH Earnings & Revenue Growth as at Feb 2026 We've flagged 3 risks for Guardant Health. See which could impact your investment. AdvertisementQuick Assessment  ✅ Price vs Analyst Target: At US$102.76, Guardant Health trades about 18% below the US$125.24 analyst price target. ✅ Simply Wall St Valuation: Shares are flagged as trading roughly 33.3% below an estimate of fair value. ❌ Recent Momentum: The stock has seen a 3.9% decline over the past 30 days.  There is only one way to know the right time to buy, sell or hold Guardant Health. Head to Simply Wall St's\ncompany report for the latest analysis of Guardant Health's Fair Value. Key Considerations  📊 The grant program ties the Shield test directly to public health goals. This may shape how you view the durability of real world demand. 📊 Keep an eye on test volumes, reimbursement developments, and how far the program reaches into underserved communities during and after Colorectal Cancer Awareness Month. ⚠️ The company carries negative shareholders' equity and remains unprofitable. Funding free access initiatives alongside ongoing losses is an important risk factor to track.  Dig Deeper For the full picture including more risks and rewards, check out the\ncomplete Guardant Health analysis. Alternatively, you can visit the\ncommunity page for Guardant Health to see how other investors believe this latest news will impact the company's narrative.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2611648681","isCrawlerRequest":true}